Andrea J. Corcoran

Former Secretary & General Counsel at Tolerx, Inc.

Andrea J. Corcoran

Andrea J. Corcoran

Former Secretary & General Counsel at Tolerx, Inc.

Overview
Career Highlights

Tolerx, Inc.
Idenix Pharmaceuticals, Inc.

RelSci Relationships

343

Number of Boards

4

Birthday

1963

Age

55

Relationships
RelSci Relationships are individuals Andrea J. Corcoran likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Providence College

Relationship likelihood: Strong

Chairman at Rhode Island Hospital

Relationship likelihood: Strong

Former Chief Financial Officer & Director at eMindful, Inc.

Relationship likelihood: Strong

Member, Business Advisory Council at Providence College

Relationship likelihood: Strong

Senior Vice President at JPMorgan Chase & Co.

Relationship likelihood: Strong

Founder at ASA International Ltd.

Relationship likelihood: Strong

Member, Business Advisory Council at Providence College

Relationship likelihood: Strong

Member, Business Advisory Council at Providence College

Relationship likelihood: Strong

Former Executive Vice President & Chief Financial Officer at The WhiteWave Foods Co.

Relationship likelihood: Strong

Director at Moody's Analytics, Inc.

Relationship likelihood: Strong

Paths to Andrea J. Corcoran
Potential Connections via
Relationship Science
You
Andrea J. Corcoran
Former Secretary & General Counsel at Tolerx, Inc.
Education
BS

Providence College (also known as Providence or "PC") is a private, coeducational, Roman Catholic university located about two miles west of downtown Providence, Rhode Island, United States, the state's capital city. It is the only college or university in North America administered by the Dominican Friars.

JD

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

Career History
Secretary & General Counsel
2007 - Prior

Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.

General Counsel & Executive Vice President, Administration
Prior

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.

Senior Vice President-Finance & Strategy
2012 - Prior

iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals. The company was founded on April 15, 1993 and is headquartered in New York, NY.

Boards & Committees
Member, Board of Directors
Prior - 2015

Slater Technology Fund invests in companies located in the US, primarily in Rhode Island State with outstanding management teams, sustainable technology, strong business models and high profitability. The fund targets companies operating in the fields of life sciences, software, internet & media, energy & environmental technology and information technology. It provides financing for start up/seed and early-stage capital requirements, where invests up to $3 million annually.

Member, Business Advisory Council
Current

Providence College (also known as Providence or "PC") is a private, coeducational, Roman Catholic university located about two miles west of downtown Providence, Rhode Island, United States, the state's capital city. It is the only college or university in North America administered by the Dominican Friars.

Member
Current

PROJECT HOPE IS A MULTI-SERVICE AGENCY AT THE FOREFRONT OF EFFORTS IN BOSTON TO MOVE FAMILIES BEYOND HOMELESSNESS AND POVERTY. WE PROVIDE LOW-INCOME WOMEN WITH CHILDREN ACCESS TO EDUCATION, JOBS, HOUSING, AND EMERGENCY SERVICES. WE FOSTER PERSONAL TRANSFORMATION AND WORK WITH THE COMMUNITY AND STATE FOR BROADER SYSTEMS CHANGE.

Member, Board of Directors
Prior - 2015

Slater Technology Fund Inc invests in companies located in the US, primarily in Rhode Island State with outstanding management teams, sustainable technology, strong business models and high profitability. It targets companies operating in the fields of life sciences, software, internet & media, energy & environmental technology and information technology. It provides financing for start up/seed and early-stage capital requirements, where invests up to $3 million annually.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2011

PROJECT HOPE IS A MULTI-SERVICE AGENCY AT THE FOREFRONT OF EFFORTS IN BOSTON TO MOVE FAMILIES BEYOND HOMELESSNESS AND POVERTY. WE PROVIDE LOW-INCOME WOMEN WITH CHILDREN ACCESS TO EDUCATION, JOBS, HOUSING, AND EMERGENCY SERVICES. WE FOSTER PERSONAL TRANSFORMATION AND WORK WITH THE COMMUNITY AND STATE FOR BROADER SYSTEMS CHANGE.

N/A
2008

PROJECT HOPE IS A MULTI-SERVICE AGENCY AT THE FOREFRONT OF EFFORTS IN BOSTON TO MOVE FAMILIES BEYOND HOMELESSNESS AND POVERTY. WE PROVIDE LOW-INCOME WOMEN WITH CHILDREN ACCESS TO EDUCATION, JOBS, HOUSING, AND EMERGENCY SERVICES. WE FOSTER PERSONAL TRANSFORMATION AND WORK WITH THE COMMUNITY AND STATE FOR BROADER SYSTEMS CHANGE.

N/A
2007

PROJECT HOPE IS A MULTI-SERVICE AGENCY AT THE FOREFRONT OF EFFORTS IN BOSTON TO MOVE FAMILIES BEYOND HOMELESSNESS AND POVERTY. WE PROVIDE LOW-INCOME WOMEN WITH CHILDREN ACCESS TO EDUCATION, JOBS, HOUSING, AND EMERGENCY SERVICES. WE FOSTER PERSONAL TRANSFORMATION AND WORK WITH THE COMMUNITY AND STATE FOR BROADER SYSTEMS CHANGE.

Political Donations
$250
2012

Governor at Rhode Island Office of the Governor, Gina Raimondo

$250
2010

Governor at Rhode Island Office of the Governor, Gina Raimondo

Transactions
Details Hidden

Idenix Pharmaceuticals, Inc. issued Common Stock